Free shipping on all orders over $ 500

Glibenclamide

Cat. No. M3547
Glibenclamide Structure
Synonym:

Glyburide; RP-1127; BIIB093

Size Price Availability Quantity
Free Sample (1-2 mg)  USD 0 In stock
500mg USD 51  USD51 In stock
1g USD 65  USD65 In stock
5g USD 77  USD77 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Glibenclamide (Glyburide) is an orally active ATP-sensitive K+ channel (KATP) inhibitor. Glibenclamide inhibits P-glycoprotein. Glibenclamide directly binds and blocks the SUR1 subunits of KATP and inhibits the cystic fibrosis transmembrane conductance regulator protein (CFTR). Glibenclamide interferes with mitochondrial bioenergetics by inducing changes on membrane ion permeability. Glibenclamide can also induce autophagy.

Glibenclamide (2 mg/kg; p.o.) increases of insulin release and rapid drop of blood glucose level in mice.

Chemical Information
Molecular Weight 494
Formula C23H28ClN3O5S
CAS Number 10238-21-8
Solubility (25°C) DMSO > 100 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Żaneta Kimber-Trojnar, et al. Is glyburide safe in pregnancy?

[2] Selvan Ravindran, et al. Metabolic profile of glyburide in human liver microsomes using LC-DAD-Q-TRAP-MS/MS

[3] Olga L Zharikova, et al. Kinetics of glyburide metabolism by hepatic and placental microsomes of human and baboon

[4] L P Krall. Glyburide (DiaBeta): a new second-generation hypoglycemic agent

[5] G F Peart, et al. The metabolism of glyburide in subjects of known debrisoquin phenotype

Related Products
Olezarsen

Olezarsen, an N-acetylgalactosamine (GalNAc)-suffixed antisense oligonucleotide (ASO) targeting hepatic APOC3 mRNA, inhibits the production of apolipoprotein C-III (apoC-III) and can be used in studies related to familial celiac sprue syndrome (FCS).

Lumasiran

Lumasiran is a siRNA compound that reduces hepatic oxalate production by targeting ethanoic acid oxidase.

Givosiran

Givosiran is a small interfering RNA that targets hepatic aminofibrillar synthase 1 (ALAS1) messenger RNA, down-regulates ALAS1 mRNA, and prevents the accumulation of neurotoxic α-aminofibrillar acids and porphyrins, which can be used in porphyria-related studies.

Viltolarsen

Viltolarsen is a phosphorodiamidomorpholine antisense oligonucleotide that targets splicing of exon 53 of the myotonic dystrophy protein gene and can be used in the study of Duchenne muscular dystrophy (DMD).

Golodirsen

Golodirsen is a phosphodiesteric morpholino oligomer (PMO) that specifically targets exon 53 of the pre-protein mRNA of myotonic dystrophy protein culture proteins, and can be used in studies related to Duchenne muscular dystrophy (DMD).

  Catalog
Abmole Inhibitor Catalog




Keywords: Glibenclamide, Glyburide; RP-1127; BIIB093 supplier, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.